All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

14

Reset

14 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AOC 1044Phase 33 trials

    Avidity Biosciences, Inc. · DMD, Duchenne Muscular Dystrophy, Exon 44

  • DeramiocelCAP-1002, Allogeneic Cardiosphere-Derived CellsPhase 32 trials

    Capricor Inc. · Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic

  • SGT-003Phase 32 trials

    Solid Biosciences Inc. · Duchenne Muscular Dystrophy, Advanced Solid Tumor

  • Zeleciment RostudirsenDYNE-251Phase 32 trials

    Dyne Therapeutics · Duchenne Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne, Muscular Dystrophy (DMD)

  • SevasemtenPhase 24 trials

    Edgewise Therapeutics, Inc. · Becker Muscular Dystrophy, Duchenne Muscular Dystrophy

  • BrogidirsenNS-089, NCNP-02Phase 23 trials

    NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD

  • BMN 351Phase 22 trials

    BioMarin · Duchenne Muscular Dystrophy (DMD), Duchenne Muscular Dystrophy

  • ENTR-601-44Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • ENTR-601-45Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • SAT-3247Phase 22 trials

    Satellos Bioscience, Inc. · Duchenne Muscular Dystrophy, Duchenne, DMD

  • WVE-N531Phase 22 trials

    Wave Life Sciences USA, Inc. · Duchenne Muscular Dystrophy

  • NS-050NCNP-03Phase 21 trial

    NS Pharma, Inc. · Duchenne Muscular Dystrophy

  • RenadirsenDS-5141bPhase 21 trial

    Daiichi Sankyo · Duchenne Muscular Dystrophy

  • RinvaterceptKER-065Phase 21 trial

    Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.